Company · CIK 1824893
Surrozen, Inc./DE
| CIK | 1824893 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | SRZN (Nasdaq) |
| First annual or quarterly report | 2021-01-04 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294542 | 2026-03-23 | 2026-03-30 | 3 | |
| 333-287434 | 2025-05-20 | 2025-08-29 | 3 | |
| 333-286703 | 2025-04-23 | 2025-05-01 | 3 | |
| 333-278800 | 2024-04-18 | 2025-04-24 | 4 | |
| 333-259496 | 2021-09-13 | 2023-04-06 | 5 | |
| 333-263923 | 2022-03-29 | 2023-04-05 | 3 | |
| 333-268745 | 2022-12-09 | 2023-03-31 | 4 | |
| 333-249394 | 2020-10-09 | 2020-11-19 | 8 |
Filings
35| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-30 | EFFECTDeclared effective | 333-294542 | 9999999995-26-001000 |
| 2026-03-30 | 424B5Shelf takedown | 333-294542 | 0001193125-26-132378 |
| 2026-03-23 | S-3Shelf registered | 333-294542 | 0001193125-26-120016 |
| 2025-08-29 | 424B5Shelf takedown | 333-287434 | 0000950170-25-112251 |
| 2025-05-23 | EFFECTDeclared effective | 333-287434 | 9999999995-25-001737 |
| 2025-05-20 | S-3Shelf registered | 333-287434 | 0000950170-25-075238 |
| 2025-05-01 | EFFECTDeclared effective | 333-286703 | 9999999995-25-001372 |
| 2025-05-01 | 424B5Shelf takedown | 333-286703 | 0000950170-25-061898 |
| 2025-04-24 | 424B5Shelf takedown | 333-278800 | 0000950170-25-058037 |
| 2025-04-23 | S-3Shelf registered | 333-286703 | 0000950170-25-057413 |
| 2024-04-25 | EFFECTDeclared effective | 333-278800 | 9999999995-24-001131 |
| 2024-04-25 | 424B5Shelf takedown | 333-278800 | 0000950170-24-048371 |
| 2024-04-18 | S-3Shelf registered | 333-278800 | 0000950170-24-045612 |
| 2023-04-06 | EFFECTDeclared effective | 333-259496 | 9999999995-23-000841 |
| 2023-04-05 | EFFECTDeclared effective | 333-263923 | 9999999995-23-000828 |
| 2023-03-31 | 424B5Shelf takedown | 333-268745 | 0001193125-23-086966 |
| 2022-12-21 | 424B5Shelf takedown | 333-268745 | 0001193125-22-309496 |
| 2022-12-19 | EFFECTDeclared effective | 333-268745 | 9999999995-22-003585 |
| 2022-12-09 | S-3Shelf registered | 333-268745 | 0001193125-22-301907 |
| 2022-04-05 | EFFECTDeclared effective | 333-263923 | 9999999995-22-000831 |
| 2022-03-29 | EFFECTDeclared effective | 333-259496 | 9999999995-22-000751 |
| 2022-03-29 | S-1Registration filed | 333-263923 | 0001193125-22-087100 |
| 2021-11-09 | EFFECTDeclared effective | 333-259496 | 9999999995-21-004262 |
| 2021-11-08 | S-1/AAmendment | 333-259496 | 0001193125-21-323016 |
| 2021-09-13 | S-1Registration filed | 333-259496 | 0001193125-21-271554 |
| 2021-07-15 | EFFECTDeclared effective | 333-256146 | 9999999995-21-002782 |
| 2020-11-19 | 424B4Final prospectus | 333-249394 | 0001104659-20-127357 |
| 2020-11-18 | EFFECTDeclared effective | 333-249394 | 9999999995-20-003217 |
| 2020-11-12 | S-1/AAmendment | 333-249394 | 0001104659-20-123739 |
| 2020-11-06 | S-1/AAmendment | 333-249394 | 0001104659-20-122572 |
| 2020-10-27 | S-1/AAmendment | 333-249394 | 0001104659-20-118538 |
| 2020-10-26 | S-1/AAmendment | 333-249394 | 0001104659-20-117936 |
| 2020-10-13 | S-1/AAmendment | 333-249394 | 0001104659-20-114246 |
| 2020-10-09 | S-1Registration filed | 333-249394 | 0001104659-20-113567 |
| 2020-09-18 | DRSDraft made public | 377-03566 | 0001104659-20-106576 |